Collegium Pharmaceutical, Inc. <COLL.O>: Leerink Partners initiates coverage with outperform rating; price target $45
COLL•Related News
IMAX Corporation <IMAX.N>: Rosenblatt Securities raises target price to $65 from $60
IMAX•
Cocrystal Pharma doses last patient in Phase 1b norovirus challenge trial of CDI-988
COCP•
Eltek names CFO Ron Freund as CEO as Eli Yaffe retires
ELTK•
Dream Finders seeks noteholder consents to ease Beazer acquisition close
DFH•
BrilliA launches Jockey brand in Indonesia under five-year license deal
BRIA•